These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18269676)

  • 41. The need for standardization of allergenic extracts utilized in humans for diagnosis and therapy.
    Desbordes J
    Dev Biol Stand; 1975; 29():267-75. PubMed ID: 807492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compliance and acceptance problems with standardized extracts.
    Lehrer SB
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):211-7. PubMed ID: 7873061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme-linked immunosorbent assays with high sensitivity for antigen-specific and total murine IgE: a useful tool for the study of allergies in mouse models.
    Takai T; Ochiai Y; Ichikawa S; Sato E; Ogawa T; Tokura T; Kuhara T; Kawai H; Hatanaka H; Takahashi S; Ogawa H; Okumura K
    Allergol Int; 2009 Jun; 58(2):225-35. PubMed ID: 19307777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High level expression, purification and physico- and immunochemical characterisation of recombinant Pen a 1: a major allergen of shrimp.
    Albrecht M; Alessandri S; Conti A; Reuter A; Lauer I; Vieths S; Reese G
    Mol Nutr Food Res; 2008 Nov; 52 Suppl 2():S186-95. PubMed ID: 18727010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An antibody-based ELISA for quantification of Ani s 1, a major allergen from Anisakis simplex.
    Arilla MC; Ibarrola I; Martínez A; Monteseirín J; Conde J; Asturias JA
    Parasitology; 2008 May; 135(6):735-40. PubMed ID: 18377696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of allergen extracts.
    Slater JE
    Dev Biol (Basel); 2005; 122():145-52. PubMed ID: 16375259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Latex allergy: the sum quantity of four major allergens shows the allergenic potential of medical gloves.
    Palosuo T; Reinikka-Railo H; Kautiainen H; Alenius H; Kalkkinen N; Kulomaa M; Reunala T; Turjanmaa K
    Allergy; 2007 Jul; 62(7):781-6. PubMed ID: 17573726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory control and standardization of allergenic extracts.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):177-220. PubMed ID: 3196018
    [No Abstract]   [Full Text] [Related]  

  • 52. The principle of homologous groups in regulatory affairs of allergen products--a proposal.
    Lorenz AR; Lüttkopf D; May S; Scheurer S; Vieths S
    Int Arch Allergy Immunol; 2009; 148(1):1-17. PubMed ID: 18698143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneity of commercial timothy grass pollen extracts.
    Focke M; Marth K; Flicker S; Valenta R
    Clin Exp Allergy; 2008 Aug; 38(8):1400-8. PubMed ID: 18564332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically modified allergens.
    Niederberger V; Valenta R
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):727-38. PubMed ID: 15474868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EAACI 'Standards for practical allergen-specific immunotherapy'.
    Madsen F
    Allergy; 2007 Mar; 62(3):332. PubMed ID: 17298352
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of allergen vaccine potency.
    Esch RE
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):402-6. PubMed ID: 16899202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures.
    Karnaukhova E; Golding B; Ophir Y
    Biologicals; 2007 Oct; 35(4):285-95. PubMed ID: 17257853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.